Foley Partner Kristel Schorr, chair of the firm’s Chemical, Biotechnology & Pharmaceutical Practice and member of the Life Sciences Industry Team, will be speaking in Boston at this year’s Women Leaders in Life Sciences Law conference presented by the American Conference Institute. Ms. Schorr’s panel will take place at 3:45 p.m. ET on Thursday, July 25, and will address:
Patent Eligibility: Understanding How New 101 Decisions are Impacting the Industry
Ingenuity is the mother of invention. In the life sciences industry, patents are the means by which this ingenuity is protected. In the patent world, section 101 eligibility determines what is patentable and which inventions are worthy of these protections. In the last few years, 101 eligibility has been a source of great debate and controversy. We will explore the latest chapter in the 101 saga.
- Peeling back the USPTO revisions; a closer look at 101 guidance
- Analyzing recent updates to PEG
- Discussing “close call” examples on subject matter eligibility
- Addressing the drawbacks and pitfalls of the 101-review process
- Examining Congressional activity addressing 101 patent eligibility dilemmas
- Proposed legislation
- Assessing the positive and negative effects of these developments on the life sciences industry
To learn more and register for this event, visit the conference website
